questionsmedicales.fr
Environnement et santé publique
Santé publique
Facteurs épidémiologiques
Facteurs épidémiologiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
Diagnostic
5
Épidémiologie
Analyse statistique
Enquête épidémiologique
Registre de santé
Étude de cohorte
Incidence
Facteurs environnementaux
Étude de cas-témoins
Surveillance épidémiologique
Tendances des maladies
Symptômes
5
Génétique
Comportements de santé
Maladies infectieuses
Symptômes
Facteurs socio-économiques
Accès aux soins
Prévention
5
Vaccination
Éducation à la santé
Interventions préventives
Populations à risque
Sensibilisation
Comportements sains
Politiques de santé publique
Réduction des risques
Programmes de dépistage
Résultats de santé
Traitements
5
Épidémies
Caractéristiques de la maladie
Traitements préventifs
Incidence
Essais cliniques
Résultats de santé
Ressources de santé
Besoins locaux
Complications
5
Surcharge des systèmes de santé
Mortalité
Santé publique
Coûts de santé
Groupes d'âge
Complications
Qualité de vie
Besoins de soins
Interventions précoces
Suivi des patients
Facteurs de risque
5
Facteurs de risque
Comportements de santé
Pollution
Accès aux soins
Antécédents familiaux
Maladies génétiques
Mode de vie
Maladies chroniques
Études épidémiologiques
Données de santé publique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs épidémiologiques : Questions médicales les plus fréquentes",
"headline": "Facteurs épidémiologiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs épidémiologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-10",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs épidémiologiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Santé publique",
"url": "https://questionsmedicales.fr/mesh/D011634",
"about": {
"@type": "MedicalCondition",
"name": "Santé publique",
"code": {
"@type": "MedicalCode",
"code": "D011634",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteurs âges",
"alternateName": "Age Factors",
"url": "https://questionsmedicales.fr/mesh/D000367",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs âges",
"code": {
"@type": "MedicalCode",
"code": "D000367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Âge de début",
"alternateName": "Age of Onset",
"url": "https://questionsmedicales.fr/mesh/D017668",
"about": {
"@type": "MedicalCondition",
"name": "Âge de début",
"code": {
"@type": "MedicalCode",
"code": "D017668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Âge maternel",
"alternateName": "Maternal Age",
"url": "https://questionsmedicales.fr/mesh/D008423",
"about": {
"@type": "MedicalCondition",
"name": "Âge maternel",
"code": {
"@type": "MedicalCode",
"code": "D008423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.250.550"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Biais (épidémiologie)",
"alternateName": "Bias",
"url": "https://questionsmedicales.fr/mesh/D015982",
"about": {
"@type": "MedicalCondition",
"name": "Biais (épidémiologie)",
"code": {
"@type": "MedicalCode",
"code": "D015982",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Biais de l'observateur",
"alternateName": "Observer Variation",
"url": "https://questionsmedicales.fr/mesh/D015588",
"about": {
"@type": "MedicalCondition",
"name": "Biais de l'observateur",
"code": {
"@type": "MedicalCode",
"code": "D015588",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Biais de sélection",
"alternateName": "Selection Bias",
"url": "https://questionsmedicales.fr/mesh/D015983",
"about": {
"@type": "MedicalCondition",
"name": "Biais de sélection",
"code": {
"@type": "MedicalCode",
"code": "D015983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Causalité",
"alternateName": "Causality",
"url": "https://questionsmedicales.fr/mesh/D015984",
"about": {
"@type": "MedicalCondition",
"name": "Causalité",
"code": {
"@type": "MedicalCode",
"code": "D015984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.625"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteurs précipitants",
"alternateName": "Precipitating Factors",
"url": "https://questionsmedicales.fr/mesh/D015985",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs précipitants",
"code": {
"@type": "MedicalCode",
"code": "D015985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.625.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Comorbidité",
"alternateName": "Comorbidity",
"url": "https://questionsmedicales.fr/mesh/D015897",
"about": {
"@type": "MedicalCondition",
"name": "Comorbidité",
"code": {
"@type": "MedicalCode",
"code": "D015897",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.687"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Multimorbidité",
"alternateName": "Multimorbidity",
"url": "https://questionsmedicales.fr/mesh/D000076322",
"about": {
"@type": "MedicalCondition",
"name": "Multimorbidité",
"code": {
"@type": "MedicalCode",
"code": "D000076322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.687.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de confusion (épidémiologie)",
"alternateName": "Confounding Factors, Epidemiologic",
"url": "https://questionsmedicales.fr/mesh/D015986",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de confusion (épidémiologie)",
"code": {
"@type": "MedicalCode",
"code": "D015986",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.718"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Modificateur d'effet épidémiologique",
"alternateName": "Effect Modifier, Epidemiologic",
"url": "https://questionsmedicales.fr/mesh/D015987",
"about": {
"@type": "MedicalCondition",
"name": "Modificateur d'effet épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015987",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Effet de cohorte",
"alternateName": "Cohort Effect",
"url": "https://questionsmedicales.fr/mesh/D015988",
"about": {
"@type": "MedicalCondition",
"name": "Effet de cohorte",
"code": {
"@type": "MedicalCode",
"code": "D015988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Effet du travailleur en bonne santé",
"alternateName": "Healthy Worker Effect",
"url": "https://questionsmedicales.fr/mesh/D015989",
"about": {
"@type": "MedicalCondition",
"name": "Effet du travailleur en bonne santé",
"code": {
"@type": "MedicalCode",
"code": "D015989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Effet placebo",
"alternateName": "Placebo Effect",
"url": "https://questionsmedicales.fr/mesh/D015990",
"about": {
"@type": "MedicalCondition",
"name": "Effet placebo",
"code": {
"@type": "MedicalCode",
"code": "D015990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Effet nocebo",
"alternateName": "Nocebo Effect",
"url": "https://questionsmedicales.fr/mesh/D064786",
"about": {
"@type": "MedicalCondition",
"name": "Effet nocebo",
"code": {
"@type": "MedicalCode",
"code": "D064786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Effet nocebo",
"alternateName": "Nocebo Effect",
"url": "https://questionsmedicales.fr/mesh/D064786",
"about": {
"@type": "MedicalCondition",
"name": "Effet nocebo",
"code": {
"@type": "MedicalCode",
"code": "D064786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.734.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antécédents gynécologiques et obstétricaux",
"alternateName": "Reproductive History",
"url": "https://questionsmedicales.fr/mesh/D017584",
"about": {
"@type": "MedicalCondition",
"name": "Antécédents gynécologiques et obstétricaux",
"code": {
"@type": "MedicalCode",
"code": "D017584",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gravidité",
"alternateName": "Gravidity",
"url": "https://questionsmedicales.fr/mesh/D020073",
"about": {
"@type": "MedicalCondition",
"name": "Gravidité",
"code": {
"@type": "MedicalCode",
"code": "D020073",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Parité",
"alternateName": "Parity",
"url": "https://questionsmedicales.fr/mesh/D010298",
"about": {
"@type": "MedicalCondition",
"name": "Parité",
"code": {
"@type": "MedicalCode",
"code": "D010298",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.812.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Intervalle sériel de l'infection",
"alternateName": "Serial Infection Interval",
"url": "https://questionsmedicales.fr/mesh/D000088822",
"about": {
"@type": "MedicalCondition",
"name": "Intervalle sériel de l'infection",
"code": {
"@type": "MedicalCode",
"code": "D000088822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteurs sexuels",
"alternateName": "Sex Factors",
"url": "https://questionsmedicales.fr/mesh/D012737",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs sexuels",
"code": {
"@type": "MedicalCode",
"code": "D012737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndémique",
"alternateName": "Syndemic",
"url": "https://questionsmedicales.fr/mesh/D000076603",
"about": {
"@type": "MedicalCondition",
"name": "Syndémique",
"code": {
"@type": "MedicalCode",
"code": "D000076603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.490.937"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Facteurs épidémiologiques",
"alternateName": "Epidemiologic Factors",
"code": {
"@type": "MedicalCode",
"code": "D015981",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J X Chen",
"url": "https://questionsmedicales.fr/author/J%20X%20Chen",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China."
}
},
{
"@type": "Person",
"name": "L G Tian",
"url": "https://questionsmedicales.fr/author/L%20G%20Tian",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China."
}
},
{
"@type": "Person",
"name": "Rong Zhang",
"url": "https://questionsmedicales.fr/author/Rong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
},
{
"@type": "Person",
"name": "Yanyan Hu",
"url": "https://questionsmedicales.fr/author/Yanyan%20Hu",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
},
{
"@type": "Person",
"name": "Hongwei Zhou",
"url": "https://questionsmedicales.fr/author/Hongwei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06083-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39014498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08334-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03734-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37145134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07055-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D015981"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs épidémiologiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs épidémiologiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs épidémiologiques",
"description": "Comment évaluer les facteurs épidémiologiques d'une maladie ?\nQuels outils sont utilisés pour le diagnostic épidémiologique ?\nQuelle est l'importance des études de cohorte ?\nComment les facteurs environnementaux sont-ils diagnostiqués ?\nQuel rôle joue la surveillance épidémiologique ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs épidémiologiques",
"description": "Quels symptômes peuvent indiquer une épidémie ?\nComment les symptômes varient-ils selon les populations ?\nQuels symptômes sont liés aux maladies infectieuses ?\nLes symptômes peuvent-ils être influencés par des facteurs socio-économiques ?\nComment les symptômes psychologiques sont-ils pris en compte ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs épidémiologiques",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment les facteurs épidémiologiques influencent-ils la prévention ?\nQuel rôle joue la sensibilisation dans la prévention ?\nComment les politiques de santé publique influencent-elles la prévention ?\nLes programmes de dépistage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs épidémiologiques",
"description": "Quels traitements sont influencés par des facteurs épidémiologiques ?\nComment les traitements sont-ils adaptés aux épidémies ?\nQuel est l'impact des traitements préventifs ?\nComment évaluer l'efficacité des traitements ?\nLes traitements varient-ils selon les régions géographiques ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs épidémiologiques",
"description": "Quelles complications peuvent survenir lors d'épidémies ?\nComment les complications affectent-elles la santé publique ?\nLes complications varient-elles selon les groupes d'âge ?\nQuel est l'impact des complications sur la qualité de vie ?\nComment prévenir les complications liées aux maladies ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs épidémiologiques",
"description": "Quels sont les principaux facteurs de risque épidémiologiques ?\nComment les facteurs environnementaux influencent-ils les risques ?\nLes antécédents familiaux sont-ils des facteurs de risque ?\nQuel rôle joue le mode de vie dans les facteurs de risque ?\nComment les facteurs de risque sont-ils identifiés ?",
"url": "https://questionsmedicales.fr/mesh/D015981?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les facteurs épidémiologiques d'une maladie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des études épidémiologiques et des analyses statistiques."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic épidémiologique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enquêtes, les registres de santé et les bases de données sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des études de cohorte ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'observer l'incidence des maladies sur des groupes spécifiques dans le temps."
}
},
{
"@type": "Question",
"name": "Comment les facteurs environnementaux sont-ils diagnostiqués ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études de cas-témoins et des analyses de l'exposition environnementale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la surveillance épidémiologique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de détecter et de suivre les tendances des maladies dans la population."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une épidémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation soudaine de cas similaires dans une population peut être un indicateur."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les populations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de la génétique, de l'environnement et des comportements."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux maladies infectieuses ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux et douleurs musculaires sont souvent associés aux infections."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être influencés par des facteurs socio-économiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions socio-économiques peuvent affecter l'accès aux soins et la santé globale."
}
},
{
"@type": "Question",
"name": "Comment les symptômes psychologiques sont-ils pris en compte ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent évalués dans le cadre d'études sur la santé mentale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination et l'éducation à la santé sont des stratégies clés."
}
},
{
"@type": "Question",
"name": "Comment les facteurs épidémiologiques influencent-ils la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier les populations à risque et à cibler les interventions préventives."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la sensibilisation dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sensibilisation augmente la connaissance des risques et encourage des comportements sains."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé publique influencent-elles la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles établissent des directives et des ressources pour réduire les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les programmes de dépistage sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de détecter précocement les maladies et d'améliorer les résultats de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont influencés par des facteurs épidémiologiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent varier selon la prévalence des maladies dans une population donnée."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils adaptés aux épidémies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont ajustés en fonction des caractéristiques de la maladie et des populations touchées."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements préventifs réduisent l'incidence des maladies dans les populations à risque."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des essais cliniques et des études de suivi sur les résultats de santé."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon les régions géographiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des ressources et des besoins locaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors d'épidémies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la surcharge des systèmes de santé et l'augmentation de la mortalité."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la santé publique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des coûts élevés et des défis pour la gestion des soins de santé."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les groupes d'âge ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes et les personnes âgées peuvent avoir des complications différentes."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des complications sur la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie et augmenter le besoin de soins."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des interventions précoces et un suivi régulier des patients à risque."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque épidémiologiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe, le statut socio-économique et les comportements de santé."
}
},
{
"@type": "Question",
"name": "Comment les facteurs environnementaux influencent-ils les risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution, le climat et l'accès aux soins peuvent augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils des facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux peuvent prédisposer à certaines maladies génétiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils identifiés ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques et des analyses de données de santé publique."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
1Department of Clinical Microbiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009 People's Republic of China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
2Zhejiang Provincial Hospital of TCM, Hangzhou, 310006 Zhejiang China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
Centre of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014 Zhejiang China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Affiliations :
Hangzhou Third Hospital, Hangzhou, 310009 Zhejiang China.
Publications dans "Facteurs épidémiologiques" :
2 publications dans cette catégorie
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
PhD Program in Conservation Medicine, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
Facultad de Ciencias de la Vida, Centro de Investigación para la Sustentabilidad, Universidad Andres Bello, Santiago, Chile.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN, United States.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
EPIVET Analysis & Solutions, Santiago, Chile.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
Centro de Vigilancia Sanitaria Veterinaria (VISAVET), Universidad Complutense, Madrid, Spain.
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense, Madrid, Spain.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
EPIVET Analysis & Solutions, Santiago, Chile.
Escuela de Medicina Veterinaria, Facultad de Agronomía e Ingeniería Forestal, Facultad de Ciencias Biológicas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
EPIVET Analysis & Solutions, Santiago, Chile.
Escuela de Medicina Veterinaria, Facultad de Agronomía e Ingeniería Forestal, Facultad de Ciencias Biológicas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Publications dans "Facteurs épidémiologiques" :
1 publication dans cette catégorie
Affiliations :
General Surgery, Marshfield Medical Center, 1000 North Oak Avenue, Marshfield, WI 54449, USA.
Publications dans "Facteurs épidémiologiques" :
Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analys...
Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after i...
A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Sur...
Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined....
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Topical drugs are often used as first-line treatment for dermatological conditions. A within-person design may then be well adapted: it consists of randomizing lesions/body sites rather than patients,...
The aim of this review was to provide a methodological overview of within-person randomized trials (WP-RCTs) in dermatology....
We searched for eligible trials published between 2017 and 2021 in MEDLINE, Embase, and Central in dermatology journals and the 6 highest-impact-factor general medical journals. Two authors selected p...
From 1,034 articles identified, we included 54 WP-RCTs, mainly for acne vulgaris, psoriasis, actinic keratosis, and atopic dermatitis. In most of the trials, patients had only 2 lesions/body sites. In...
Our systematic review highlights that despite the publication of the CONSORT checklist extension for WP-RCTs in 2017, this design is rarely used, and when it is, there are methodological and reporting...
We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, Chin...
Vulvar lichen sclerosus (LS) is a chronic debilitating inflammatory skin disease. Today, the gold standard is a life-long topical steroid treatment. Alternative options are highly desired. We present ...
We recruited 66 patients, 44 in the laser arm and 22 in the steroid arm. Patients with a physician-administered clinical LS score ≥ 4 were included. Participants received either four laser treatments ...
The findings of this trial have the potential to offer a novel treatment option for LS. The standardized Nd:YAG/Er:YAG laser settings and the treatment regime are presented in this paper....
NCT03926299....
Alopecia areata (AA) is a common autoimmune skin disease. Our study aimed to systematically evaluate the efficacy and safety of compound glycyrrhizin (CG) combined with topical minoxidil therapy in tr...
We searched the PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP databases. Randomized controlled trials (RCTs) on CG combined with topical minoxidil therapy compared with topi...
11 RCTs and 1189 patients were included. Compared with topical minoxidil therapy alone, CG combined with topical minoxidil therapy was more effective at improving the clinical efficacy (RR = 1.36, 95%...
The current evidence indicates that CG combined with topical minoxidil therapy is effective and safe for AA. However, owing to the suboptimal quality of the included studies, more high-quality and lar...
The purpose was to identify and summarize the existing evidence on the efficacy and safety of the topical application of olive oil for preventing pressure ulcers (PUs). We included only randomized con...
To investigate the clinical efficacy and safety of topical difamilast in mild-to-moderate atopic dermatitis (AD)....
Only randomized controlled trials (RCTs) that compared topical difamilast with vehicle treatment for patients with AD were included. PubMed, Web of Science, Ovid Medline, Cochrane Library, ClinicalTri...
Five studies enrolling a total of 1009 patients with mild-to-moderate AD were identified. Compared with the topical vehicle, topical difamilast was associated with a significantly higher success rate ...
This meta-analysis suggests that topical difamilast is an effective and safe treatment for mild-to-moderate AD....
Melasma is a chronic relapsing skin condition. Laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) increases the efficacy of laser therapy in mela...
Randomized controlled trials are used to estimate the causal effect of a treatment on a health outcome of interest in a patient population. Often the specified treatment in a randomized controlled tri...
We use causal reasoning to explain why randomized controlled trials of biomarker targets can arrive at conflicting or misleading conclusions. We describe four key threats to the validity of trials of ...
We illustrate these findings using evidence from 15 randomized controlled trials of blood pressure targets for management of hypertension. Randomized trials of blood pressure targets exhibit substanti...
Researchers should critically assess meta-analyses of trials of targets for variation in the types, distributions, and off-target effects of therapies studied. Trial investigators should release detai...